Daclizumab Injection Clinical Trials

• Treatment of Active Anterior Uveitis Associated with JIA, Using Humanized Anti-Tac (HAT, Daclizumab)
  ClinicalTrials.gov Identifier: NCT00130637 - Recruiting
  Anterior Uveitis; Arthritis, Juvenile Idiopathic; Daclizumab; Iritis; Immunosuppression
  
• Daclizumab and Sirolimus to Treat Uveitis
  ClinicalTrials.gov Identifier: NCT00078689 - Active, not recruiting
  Uveitis
  
• A Study to Determine whether Therapy with Daclizumab Will Benefit Patients with Bone Marrow Failure
  ClinicalTrials.gov Identifier: NCT00001962 - Recruiting
  Aplastic Anemia; Pure Red Cell Aplasia; Thrombocytopenic Purpura
  
• Daclizumab to Treat HIV-Infected Patients
  ClinicalTrials.gov Identifier: NCT00080431 - Active, not recruiting
  HIV Infections
  
• New Onset of Type 1 Diabetes Mycophenolate Mofetil-Daclizumab Clinical Trial
  ClinicalTrials.gov Identifier: NCT00100178 - Active, not recruiting
  Diabetes Mellitus, Type 1
  
• Mycophenolate Mofetil, Tacrolimus, Daclizumab, and Donor Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00006350 - Active, not recruiting
  Leukemia; Lymphoma; Multiple Myeloma
  
• Zenapax (Daclizumab) to Treat Relapsing Remitting Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00071838 - Active, not recruiting
  Multiple Sclerosis, Relapsing-Remitting
  
• Methylprednisolone With or Without Daclizumab in Treating Patients With Acute Graft-Versus-Host Disease
  ClinicalTrials.gov Identifier: NCT00053976 - Active, not recruiting
  Graft Versus Host Disease
  
• Daclizumab Experience in Pediatric Heart Transplant
  ClinicalTrials.gov Identifier: NCT00486057 - Active, not recruiting
  Congenital Disorders
  
• MMF, Daclizumab and Corticosteroids as Mainstay Immunosuppression in Renal Transplant Patients
  ClinicalTrials.gov Identifier: NCT00231764 - Active, not recruiting
  Kidney Transplantation
  
• TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00057720 - Active, not recruiting
  Ovarian Neoplasms
  
• Daclizumab Injections to Treat Non-infectious Sight-threatening Uveitis
  ClinicalTrials.gov Identifier: NCT00043667 - Completed
  Uveitis
  
• Daclizumab to Treat Non-Infectious Sight-Threatening Uveitis
  ClinicalTrials.gov Identifier: NCT00070759 - Completed
  Uveitis
  
• Study of Daclizumab in Patients with Chronic, Persistent Asthma
  ClinicalTrials.gov Identifier: NCT00028288 - Completed
  Asthma
  
• Use of Daclizumab for the Prevention of Allograft Rejection in Pediatric Heart Transplant Patients
  ClinicalTrials.gov Identifier: NCT00284531 - Recruiting
  Cardiac Transplantation
  
• Daclizumab to Treat Chronic Immune Thrombocytopenia
  ClinicalTrials.gov Identifier: NCT00049725 - Completed
  Thrombocytopenia
  
• To study the use of Humanized CD25 in preventing the relapse of Psoriasis Vulgaris
  ClinicalTrials.gov Identifier: NCT00050661 - Active, not recruiting
  Psoriasis
  
• A Randomized Trial of Recombinant Humanized Anti-IL-2 Receptor Antibody (Daclizumab) Versus Antithymocyte Globulin (ATG) to Treat the Cytopenia of Myelodysplastic Syndrome (MDS)
  ClinicalTrials.gov Identifier: NCT00072969 - Completed
  Myelodysplastic Syndromes
  
• Anti Cytokine Combination Therapy With Daclizumab and Infliximab for Treatment of Steroid Refractory Acute GVHD
  ClinicalTrials.gov Identifier: NCT00574470 - Recruiting
  Graft vs Host Disease
  
• Study of Subcutaneous Daclizumab in Patients with Active, Relapsing Forms of Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00109161 - Completed
  Multiple Sclerosis
  
• Daclizumab in Treating Patients With Adult T-Cell Leukemia/Lymphoma
  ClinicalTrials.gov Identifier: NCT00020020 - Recruiting
  Lymphoma
  
• Pediatric Kidney Transplant without Calcineurin Inhibitors
  ClinicalTrials.gov Identifier: NCT00023231 - Active, not recruiting
  End-Stage Renal Disease
  
• Suppressing the Immune System With or Without Steroids in Children Who Have Received Kidney Transplants
  ClinicalTrials.gov Identifier: NCT00141037 - Active, not recruiting
  Kidney Diseases; Kidney Transplantation
  
• Penile Injection Anxiety
  ClinicalTrials.gov Identifier: NCT00582231 - Recruiting
  Penile Injection Therapy; Erectile Dysfunction; Radical Pelvic Surgery
  
• Islet Cell Transplants for Diabetes
  ClinicalTrials.gov Identifier: NCT00014911 - Active, not recruiting
  Diabetes Mellitus, Insulin-Dependent
  
• Tacrolimus and Daclizumab Versus Tacrolimus and Steroids in Liver Recipients Receiving Sub-Optimal Grafts
  ClinicalTrials.gov Identifier: NCT00321074 - Recruiting
  Liver Transplantation
  
• Infliximab, Sirolimus and Daclizumab to Treat Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00304954 - Recruiting
  Macular Degeneration; Neovascularization
  
• Safety of KAI-9803 for Injection with Angioplasty following Heart Attack
  ClinicalTrials.gov Identifier: NCT00093197 - Active, not recruiting
  Myocardial Infarction
  
• A Study to Evaluate the Effects of Two Vitamin D Analogs, Zemplar® Injection and Hectorol® Injection, on Intestinal Absorption of Calcium in Patients With Stage 5 Chronic Kidney Disease
  ClinicalTrials.gov Identifier: NCT00257920 - Recruiting
  Stage 5 Chronic Kidney Disease (CKD); Secondary Hyperparathyroidism
  
• Humanized anti-IL-2 receptor monoclonal antibody in moderate-to-severe ulcerative colitis
  ClinicalTrials.gov Identifier: NCT00073047 - Active, not recruiting
  Ulcerative Colitis; Gastrointestinal Disease; Inflammatory Bowel Disease
  
• Study of TLK199 HCl Liposomes for Injection in Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00035867 - Active, not recruiting
  Myelodysplastic Syndromes
  
• Daclizumab to Treat Wegener's Granulomatosis
  ClinicalTrials.gov Identifier: NCT00040248 - Completed
  Wegener's Granulomatosis
  
• Preoperative Injection of Bevacizumab Prior to Vitreoretinal Surgery in Diabetic Tractional Retinal Detachment
  ClinicalTrials.gov Identifier: NCT00548197 - Recruiting
  Intravitreal Bevacizumab Injection; Pars Plana Vitrectomy; Tractional Retinal Detachment; Diabetic Retinopathy
  
• Adverse Drug Reactions of Different Brands of Ceftazidime Injection
  ClinicalTrials.gov Identifier: NCT00173901 - Active, not recruiting
  Infection
  
• Topical Amethocaine Gel for Intramuscular Injection in Term Neonates
  ClinicalTrials.gov Identifier: NCT00267111 - Active, not recruiting
  Pain
  
• Validation of Self-Reported Needle Sharing Among Injection Drug Users
  ClinicalTrials.gov Identifier: NCT00341081 - Active, not recruiting
  Viral Infection
  
• EPC by Intracoronary Injection in Patients With Chronic Stable Angina
  ClinicalTrials.gov Identifier: NCT00384514 - Active, not recruiting
  Coronary Artery Disease
  
• A Effectiveness and Safety Study of AQUAVAN® Injection (AQUAVAN; Fospropofol Disodium) for Sedation During Colonoscopy
  ClinicalTrials.gov Identifier: NCT00125424 - Active, not recruiting
  Colonoscopy; Colon Polyps; Endoscopic sedation; Endoscopic outcomes; Endoscopy
  
• The Necessity of an Injection-Meal-Interval in Patients With Type 2 Diabetes Mellitus and Therapy With Human Insulin
  ClinicalTrials.gov Identifier: NCT00529165 - Recruiting
  Diabetes Mellitus Type 2; Injection to Meal Time; Human Insulin
  
• Comparison Between Type A Botulinum Toxin Injection and Corticosteroid Injection in the Treatment of Tennis Elbow
  ClinicalTrials.gov Identifier: NCT00395616 - Recruiting
  Type A Botulinum Toxin; Tennis Elbow
  
• Safety and Effects of Implanted (Autologous) Skeletal Myoblasts (MyoCell) Using an Injection Catheter = SEISMIC Trial
  ClinicalTrials.gov Identifier: NCT00375817 - Active, not recruiting
  Myocardial Infarction; Heart Failure, Congestive
  
• Study of MEDI-522 Administered by Subcutaneous Injection to Adults With Plaque Psoriasis
  ClinicalTrials.gov Identifier: NCT00192517 - Active, not recruiting
  Psoriasis
  
• A 2-Year Study of Patients With Schizophrenia Who Are Treated With Long-Acting Risperidone Injection.
  ClinicalTrials.gov Identifier: NCT00246194 - Active, not recruiting
  Schizophrenia
  
• IOP Reduction After Anecortave Acetate Injection in Glaucoma Patients
  ClinicalTrials.gov Identifier: NCT00533962 - Active, not recruiting
  Glaucoma; Intraocular Pressure
  
• Behavioral Intervention for HIV and HCV-Uninfected Injection Drug Users
  ClinicalTrials.gov Identifier: NCT00164372 - Active, not recruiting
  HIV Infections; Hepatitis C
  
• Comparison of Efficacy Between Silicone Ahmed Glaucoma Valves With and Without Intravitreal Triamcinolone Injection
  ClinicalTrials.gov Identifier: NCT00491712 - Active, not recruiting
  Neovascular Glaucoma
  
• A Trial to Reduce Hepatitis C Among Injection Drug Users - 1
  ClinicalTrials.gov Identifier: NCT00218192 - Active, not recruiting
  HCV Negative Status; HCV Risk Behavior
  
• A Phase I/II Study of Chondrogen Delivered by Intra-Articular Injection Following Meniscectomy
  ClinicalTrials.gov Identifier: NCT00225095 - Active, not recruiting
  Recovery Following Partial Medial Meniscectomy
  
• Multicenter Study Of CPX-1 (Irinotecan HCl: Floxuridine) Liposome Injection In Patients With Advanced Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00361842 - Active, not recruiting
  Colorectal Neoplasms
  
• Doxorubicin HCI Liposome Injection Versus Weekly Docetaxel in Patients First Relapse Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00193037 - Active, not recruiting
  Breast Cancer
  
• Vitamin K Injections for the Treatment of Painful Menstruation
  ClinicalTrials.gov Identifier: NCT00104546 - Active, not recruiting
  Dysmenorrhea
  
• Injection Of AJCC Stage IIB, IIC, III And IV Melanoma Patients With A Multi-Epitope Peptide Vaccine Using GM-CSF DNA As An Adjuvant: A Pilot Trial To Assess Safety And Immunity
  ClinicalTrials.gov Identifier: NCT00580060 - Active, not recruiting
  Melanoma
  
• Safety and Efficacy Study of Daclizumab HYP to Treat Relapsing-Remitting Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00390221 - Not yet recruiting
  Multiple Sclerosis, Relapsing-Remitting
  
• Randomized Study of Interventions to Enhance Adherence to Isoniazid Prevention Therapy for Tuberculosis in Injection Drug Users
  ClinicalTrials.gov Identifier: NCT00004740 - Active, not recruiting
  Tuberculosis
  
• Safety and Efficacy of Doxorubicin Adsorbed to Magnetic Beads
  ClinicalTrials.gov Identifier: NCT00054951 - Active, not recruiting
  Hepatocellular Carcinoma
  
• Study of Pasireotide Long Acting Release (LAR) Injection in Patients With Acromegaly and Patients With Carcinoid Disease
  ClinicalTrials.gov Identifier: NCT00446082 - Active, not recruiting
  Carcinoid Tumor; Acromegaly
  
• Monoclonal Antibody Plus Interleukin-2 in Treating Patients With Leukemia or Lymphoma
  ClinicalTrials.gov Identifier: NCT00002681 - Active, not recruiting
  recurrent adult Hodgkin's lymphoma; recurrent adult acute myeloid leukemia; relapsing chronic myelogenous leukemia; ...
  
• Patients Preference With Self-Injection: The PRISM Study
  ClinicalTrials.gov Identifier: NCT00253396 - Recruiting
  Bruises
  
• Safety and Efficacy of PolyHeme(R) in Hemorrhagic Shock Following Traumatic Injuries Beginning in the Pre-Hospital Setting
  ClinicalTrials.gov Identifier: NCT00076648 - Active, not recruiting
  Hemorrhagic Shock
  
• Fluocinolone Acetonide Implant Compared to Sham Injection in Patients With Diabetic Macular Edema
  ClinicalTrials.gov Identifier: NCT00344968 - Active, not recruiting
  Diabetic Macular Edema
  
• Injection Site Study In Patients With Type 2 Diabetes Mellitus (T2DM) And Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00394030 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• Study of Taxoprexin Injection vs. Dacarbazine in Patients with Metastatic Malignant Melanoma
  ClinicalTrials.gov Identifier: NCT00087776 - Active, not recruiting
  Malignant Melanoma
  
• Insulin Glargine Injection Treatment in Place of Thiazolidinedione (TZD), Sulfonylurea, or Metformin in Triple Agent Therapy for Type 2 Diabetes Mellitus (T2DM) Adult Subjects With Unsatisfactory Control
  ClinicalTrials.gov Identifier: NCT00283049 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Study of TPI 287 in Patients with Advanced Malignancies
  ClinicalTrials.gov Identifier: NCT00113724 - Active, not recruiting
  Neoplasms
  
• A Study to Determine the Effectiveness and Safety of Risperidone in the Prevention of Bipolar Mood Episodes
  ClinicalTrials.gov Identifier: NCT00132678 - Active, not recruiting
  Bipolar Disorder
  
• Azithromycin/Bicillin for treatment of early syphilis
  ClinicalTrials.gov Identifier: NCT00031499 - Active, not recruiting
  Syphilis
  
• Treating High Risk Leukemia with CD40 Ligand & IL-2 Gene Modified Tumor Vaccine.
  ClinicalTrials.gov Identifier: NCT00058799 - Active, not recruiting
  Leukemia
  
• Intraocular Pressure Immediately Following Intravitreous Injection of Ranibizumab
  ClinicalTrials.gov Identifier: NCT00417703 - Recruiting
  Choroidal Neovascularization
  
• Botulinum Toxin Injection for the Management of BPH
  ClinicalTrials.gov Identifier: NCT00451191 - Recruiting
  Benign Prostatic Hyperplasia
  
• Dysport® Injection in the Treatment of Chronic Lateral Epicondylitis
  ClinicalTrials.gov Identifier: NCT00497913 - Recruiting
  Tennis Elbow
  
• A Phase 2 open-label clinical study using intravenous Paxceed™ to treat patients with rheumatoid arthritis
  ClinicalTrials.gov Identifier: NCT00055133 - Active, not recruiting
  Rheumatoid Arthritis
  
• ATX-101 (Sodium Deoxycholate for Injection) for the Treatment of Superficial Lipomas
  ClinicalTrials.gov Identifier: NCT00422188 - Recruiting
  Lipoma
  
• The ORIGIN Trial (Outcome Reduction with Initial Glargine Intervention)
  ClinicalTrials.gov Identifier: NCT00069784 - Active, not recruiting
  Diabetes Mellitus, Non-Insulin-Dependent
  
• Does a Single Steroid Injection Reduce the Formation of Postmastectomy Seroma
  ClinicalTrials.gov Identifier: NCT00307606 - Recruiting
  Breast Neoplasms; Mastectomy
  
• To Find the Best Dose of pVGI.1(VEGF2) to Benefit Angina Patients when given with an Experimental Injection Catheter
  ClinicalTrials.gov Identifier: NCT00090714 - Active, not recruiting
  Angina Pectoris
  
• Safety and Effectiveness of SeeMore (EVP 1001-1 Injection) for MRI in Heart Patients
  ClinicalTrials.gov Identifier: NCT00340925 - Recruiting
  Myocardial Infarction
  
• Sentinel Lymph Node Biopsy Using Peritumoral Injection With Blue Dye Confirmation
  ClinicalTrials.gov Identifier: NCT00575744 - Recruiting
  Breast Cancer
  
• An Observational Study Evaluating SYMLIN® (Pramlintide Acetate) Injection Use in Insulin Using Patients With Type 2 and Type 1 Diabetes
  ClinicalTrials.gov Identifier: NCT00229658 - Active, not recruiting
  Type 1 Diabetes Mellitus; Type 2 Diabetes Mellitus
  
• A Study to Evaluate Nutropin AQ for the Treatment of Growth Restriction in Children with Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00079742 - Active, not recruiting
  Cystic Fibrosis
  
• Injection Methods in Finding the Sentinel Lymph Node During Lymphatic Mapping and Sentinel Lymph Node Biopsy in Patients With Invasive Breast Cancer
  ClinicalTrials.gov Identifier: NCT00438477 - Active, not recruiting
  Breast Cancer
  
• Comparison Study of Operation and Percutaneous Ethanol Injection Therapy for Small, Solitary HCC
  ClinicalTrials.gov Identifier: NCT00357422 - Recruiting
  Hepatocellular Carcinoma
  
• Comparison Study of Transarterial Chemoembolization and Percutaneous Ethanol Injection for Multiple, Small HCCs
  ClinicalTrials.gov Identifier: NCT00357474 - Recruiting
  Hepatocellular Carcinoma
  
• Safety Study of IHL-305 (Irinotecan Liposome Injection) to Treat Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00364143 - Recruiting
  Cancer
  
• The Impact of an Epidural Ropivacaine-Neostigmine Injection for Perineal Analgesia at the End of Labor.
  ClinicalTrials.gov Identifier: NCT00407290 - Recruiting
  Pregnancy; Vaginal Delivery
  
• Sub-Tenon’s Injection of Triamcinolone and Ciprofloxacin in a Controlled-Release System for Cataract Surgery
  ClinicalTrials.gov Identifier: NCT00431028 - Recruiting
  Inflammation; Bacterial Infections
  
• This is a Prospective, Randomized, Double-Blind Study Comparing Intravesical Injection of Botox® to Placebo.
  ClinicalTrials.gov Identifier: NCT00479596 - Recruiting
  Overactive Bladder
  
• Phase I/II Dose Escalation Study of VELCADE® and Docetaxel in Patients with Advanced Androgen-Independent Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00064610 - Active, not recruiting
  Prostatic Neoplasms
  
• Safety and Efficacy Study of Myobloc in the Treatment of Sialorrhea (Drooling) in Patients with ALS
  ClinicalTrials.gov Identifier: NCT00125203 - Active, not recruiting
  Amyotrophic Lateral Sclerosis; Sialorrhea
  
• Intramyocardial Injection of Autologous Aldehyde Dehydrogenase-Bright Stem Cells for Therapeutic Angiogenesis
  ClinicalTrials.gov Identifier: NCT00314366 - Recruiting
  Coronary Artery Disease
  
• Corticosteroid Injection for Common Upper Extremity Problems
  ClinicalTrials.gov Identifier: NCT00438672 - Recruiting
  Lateral Elbow Pain; deQuervain’s Tendonitis; CMC Arthritis
  
• Injection of ex Vivo Amplified G-CSF Mobilised Autologous Peripheral Blood Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00461955 - Recruiting
  Multiple Myeloma
  
• A Phase 1 Safety Study of Single and Repeated Doses of JSM6427 (Intravitreal Injection) to Treat AMD
  ClinicalTrials.gov Identifier: NCT00536016 - Recruiting
  Macular Degeneration
  
• Hyaluronan Versus NaCl 20 Ml Versus Placebo in Knee Osteoarthritis
  ClinicalTrials.gov Identifier: NCT00144820 - Active, not recruiting
  Osteoarthritis, Knee
  
• Phase 2b Study of VELCADE Alone and VELCADE plus Irinotecan in Patients with Relapsed or Refractory Colorectal Carcinoma
  ClinicalTrials.gov Identifier: NCT00051987 - Active, not recruiting
  Colorectal Carcinoma
  
• Safety Study of MBP-426 (Liposomal Oxaliplatin Suspension for Injection) to Treat Advanced or Metastatic Solid Tumors
  ClinicalTrials.gov Identifier: NCT00355888 - Recruiting
  Cancer
  
• Feasibility Study of the Effect of Intra-Dermal Insulin Injection on Blood Glucose Levels After Eating
  ClinicalTrials.gov Identifier: NCT00553488 - Recruiting
  Diabetes Mellitus, Type 1
  
• Factors Predicting Efficacy of Allergen Injection Immunotherapy for Grass Pollen Hayfever: a Pilot Study.
  ClinicalTrials.gov Identifier: NCT00135629 - Active, not recruiting
  Seasonal Allergic Rhinoconjunctivitis
  
• Valganciclovir in Patients with CMV Retinitis and AIDS Who Cannot Take Drugs by Injection
  ClinicalTrials.gov Identifier: NCT00017784 - Active, not recruiting
  Cytomegalovirus Retinitis; HIV Infections
  
• Vincristine, DOXIL® (Doxorubicin HCl Liposome Injection) and Dexamethasone vs. Vincristine, Doxorubicin, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00344422 - Active, not recruiting
  M-Protein; Multiple Myeloma; Myeloma; Myeloma Proteins
  
• Depo-Provera: Evaluation of BMDensity and Total Body Ca Adolescent DP150CI Users and Non-Hormonal Contraception
  ClinicalTrials.gov Identifier: NCT00139685 - Active, not recruiting
  Contraception; Bone Density